Treatment with a drug from list 2
Peripheral neuropathy - Treatment with a drug from list 2 Factor
Last reviewed for CCPS 15 March 2006.
Investigative Documents
Medical Report - Drug Causing Peripheral Neuropathy - Peripheral neuropathy [MR9293]
Preliminary questions [32944]
there is some evidence that being treated with a drug from Specified List 2 may be a factor in the development of the condition under consideration.32946 the veteran was being treated with a drug from Specified List 2 for treatment of an illness or injury which is identifiable.
for the identified illness or injury, the veteran was being treated with a drug from Specified List 2 at the time of the clinical onset of the condition under consideration.32948 — the veteran has established the causal connection between being treated with a drug from Specified List 2 and VEA service for the clinical onset of peripheral neuropathy.
32949 — the veteran has established the causal connection between being treated with a drug from Specified List 2 and operational service for the clinical onset of peripheral neuropathy.
or
32950 — the veteran has established the causal connection between being treated with a drug from Specified List 2 and eligible service for the clinical onset of peripheral neuropathy.
Clinical onset and operational service [32949]
32951 — the identified illness or injury, for which the veteran was being treated with a drug from Specified List 2, is causally related to operational service.
Clinical onset and eligible service [32950]
the identified illness or injury was treated with a drug from Specified List 2 which is available for eligible service cases.32952 — the identified illness or injury, for which the veteran was being treated with a drug from Specified List 2, is causally related to eligible service.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/peripheral-neuropathy-f058-337033793545357/rulebase-peripheral-neuropathy/treatment-drug-list-2